Indication
Influenza A H1N1
2 clinical trials
2 products
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Dose Ranging Study Evaluating Safety, Pharmacokinetics and Clinical Benefit of FLU-IGIV in Hospitalized Patients With Serious Influenza A InfectionStatus: Completed, Estimated PCD: 2019-06-17
Product
FLU-IGIVProduct
GrippolClinical trial
Multicenter, Double-blind, Randomized, Parallel Group Study to Evaluate the Immunogenicity, Reactogenicity and Safety of the Grippol® Quadrivalent Vaccine in Children Aged 6 Months to 5 Years (Inclusive)Status: Completed, Estimated PCD: 2023-06-15